Clinical Trial Information Request for Protocol 22-117 Title A Multicenter rAndomized, open-label, blinded endpoint evaluation, phase 3 study comparinG the effect of abelacimab relative to daltepariN on venOus thromboLism (VTE) recurrence and bleeding in patients with gastroIntestinal (GI)/genitourinAry (GU) cancer associated VTE (Magnolia) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone